A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease

Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial

(2016) Daniel Weintraub et al.   MOVEMENT DISORDERS

Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease

(2015) Robert A. Hauser et al.   JAMA Neurology

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

(2013) C. Warren Olanow et al.   MOVEMENT DISORDERS

Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial

(2011) W. Poewe et al.   NEUROLOGY

The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale

(2010) Lisa M. Shulman et al.   ARCHIVES OF NEUROLOGY

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO-B) Inhibitor Rasagiline

(2010) Tamar Goren et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

(2010) Robert A. Hauser et al.   MOVEMENT DISORDERS

Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial

(2010) Karl Kieburtz et al.   MOVEMENT DISORDERS

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease

(2009) Angelo Antonini et al.   LANCET NEUROLOGY

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE